Influence of Patient Immigrant Status on Provider Diabetes Treatment Decisions: A Virtual Human Experimental Study

dc.contributor.advisorStewart, Jesse C.
dc.contributor.authorHsueh, Loretta
dc.contributor.otherHirsh, Adam T.
dc.contributor.otherZapolski, Tamika
dc.contributor.otherde Groot, Mary
dc.contributor.otherMather, Kieren J.
dc.date.accessioned2020-03-17T17:44:26Z
dc.date.available2020-03-17T17:44:26Z
dc.date.issued2020-08
dc.degree.date2020en_US
dc.degree.disciplineDepartment of Psychologyen
dc.degree.grantorPurdue Universityen_US
dc.degree.levelPh.D.en_US
dc.descriptionIndiana University-Purdue University Indianapolis (IUPUI)en_US
dc.description.abstractImmigrants are at elevated risk for not having their diabetes treatment appropriately intensified, likely resulting in poorly-controlled diabetes and increased morbidity and mortality. Immigrant status is a powerful sociodemographic cue, yet its influence on providers’ diabetes treatment decisions is unknown. The study objective was to determine the effect of patient immigrant status on providers’ decisions to (1) take no action, (2) add an oral hypoglycemic agent (OHA), (3) add/switch to insulin, or (4) refer the patient to an endocrinologist. Participants were 140 medical students/professionals (‘providers’). Providers viewed profiles (videos + vignettes) for virtual patients differing in immigrant status (born in Mexico or U.S.; other characteristics held constant). Analyses were completed at the group (‘nomothetic’) and individual (‘idiographic’) levels. Nomothetic results indicated providers were less likely to refer foreign-born patients to endocrinology than U.S.-born patients (p=0.03). No differences were detected for the other three treatment likelihood ratings. Idiographic results indicated that about half of provider decisions were influenced by patient immigrant status (i.e., Cohen’s d≥0.50) across all four treatment decisions. Effect size data show an almost even split between higher treatment ratings for foreign-born vs. U.S.-born patients for three decisions (take no action, add an OHA, add/switch to insulin), explaining why group-level differences for these ratings did not emerge (i.e., they were cancelled out). This study found that providers are less likely to refer foreign-born patients to endocrinology, potentially leading to therapeutic inertia. In addition, half of individual-level provider decisions were meaningfully influenced by patient immigrant status. However, traditional group-level analyses mask these important individual-level differences. These systematic differences in treatment based on non-relevant factors could lead to unintended adverse outcomes for the foreign-born population.en_US
dc.identifier.urihttps://hdl.handle.net/1805/22345
dc.identifier.urihttp://dx.doi.org/10.7912/C2/1142
dc.language.isoen_USen_US
dc.subjectimmigranten_US
dc.subjecttype 2 diabetesen_US
dc.subjectmedical decision-makingen_US
dc.subjectvirtual patienten_US
dc.titleInfluence of Patient Immigrant Status on Provider Diabetes Treatment Decisions: A Virtual Human Experimental Studyen_US
dc.typeThesisen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hsueh dissertation.pdf
Size:
799.56 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: